| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |